Angiotensin AT2 receptor degradation is prevented by ligand occupation

被引:27
作者
Csikós, T
Balmforth, AJ
Grojec, M
Gohlke, P
Culman, J
Unger, T
机构
[1] Univ Kiel, Inst Pharmacol, D-24105 Kiel, Germany
[2] Univ Leeds, Inst Cardiovasc Res, Leeds LS2 9JT, W Yorkshire, England
关键词
D O I
10.1006/bbrc.1997.8042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A substantial increase in [I-125]Sar(1),Ile(8)-Angiotensin II binding activity can be observed 24 hours after treatment of R3T3 cells with AT(2) receptor agonists and antagonists. An increase in the radioligand binding activity, although less profound, can also be observed 6 hours after AT(2) receptor ligand treatment, on fetal human kidney cells expressing a recombinant human AT(2) receptor. However, the increase in radioligand binding activity cannot be detected unless the ligands are removed from the cell surface by an acid-glycine (pH 3) wash, just prior to the binding assay. Interestingly, an acid-glycine wash 24 hours prior to the binding assay causes a dramatic decrease in the radioligand binding activity on untreated R3T3 cells. This decrease, which was prevented by angiotensin II treatment, suggests the existence of an unknown endogenous factor which, like the AT(2) receptor ligands, seems to prevent AT(2) receptor degradation. (C) 1998 Academic Press.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 20 条
[1]   The conformational change responsible for AT(1) receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII [J].
Balmforth, AJ ;
Lee, AJ ;
Warburton, P ;
Donnelly, D ;
Ball, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) :4245-4251
[2]  
CAMP HS, 1995, RECEPTOR, V5, P123
[3]   BIOCHEMICAL-CHARACTERIZATION OF 2 ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT [J].
DEGASPARO, M ;
WHITEBREAD, S ;
MELE, M ;
MOTANI, AS ;
WHITCOMBE, PJ ;
RAMJOUE, HP ;
KAMBER, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 :S31-S35
[4]  
DUDLEY DT, 1991, MOL PHARMACOL, V40, P360
[5]   REGULATED EXPRESSION OF ANGIOTENSIN-II (AT2) BINDING-SITES IN R3T3 CELLS [J].
DUDLEY, DT ;
SUMMERFELT, RM .
REGULATORY PEPTIDES, 1993, 44 (02) :199-206
[6]   The angiotensin AT(2) receptor down-regulates neurofilament M in PC12W cells [J].
Gallinat, S ;
Csikos, T ;
Meffert, S ;
Herdegen, T ;
Stoll, M ;
Unger, T .
NEUROSCIENCE LETTERS, 1997, 227 (01) :29-32
[7]   EXPRESSION OF AT2-RECEPTORS IN THE DEVELOPING RAT FETUS [J].
GRADY, EF ;
SECHI, LA ;
GRIFFIN, CA ;
SCHAMBELAN, M ;
KALINYAK, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) :921-933
[8]   Intracellular trafficking of angiotensin II and its AT(1) and AT(2) receptors: Evidence for selective sorting of receptor and ligand [J].
Hein, L ;
Meinel, L ;
Pratt, RE ;
Dzau, VJ ;
Kobilka, BK .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (09) :1266-1277
[9]   Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis [J].
Horiuchi, M ;
Hayashida, W ;
Kambe, T ;
Yamada, T ;
Dzau, VJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :19022-19026
[10]   MULTIPLE GROWTH-FACTORS MODULATE MESSENGER-RNA EXPRESSION OF ANGIOTENSIN-II TYPE-2 RECEPTOR IN R3T3 CELLS [J].
ICHIKI, T ;
KAMBAYASHI, Y ;
INAGAMI, T .
CIRCULATION RESEARCH, 1995, 77 (06) :1070-1076